Relationship Between Sleep Quality, Sleep Duration, Heart Rate, and Step Number

Sponsor
Tokat Gaziosmanpasa University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05829525
Collaborator
(none)
111
1
1
15
7.4

Study Details

Study Description

Brief Summary

This study aims to evaluate the relationship among sleep duration, heart rate, number of steps, and sleep quality.

Condition or Disease Intervention/Treatment Phase
  • Other: Evaluation of sleep quality, sleep duration, heart rate and step count
N/A

Detailed Description

There are studies examining the relationship between sleep quality and physical activity in young adults. In these studies, weakly significant relationships were recorded between sleep quality and physical activity level. However, in these studies, the level of physical activity was evaluated with the International Physical Activity Questionnaire and the questionnaire was filled in within the framework of certain activities. In this study, physical activity will be evaluated with the number of steps taken per day. In addition, there is no study examining the relationship between sleep quality, sleep duration, and heart rate in young adults. With the current study, parameters that will affect physical activity such as sleep duration, heart rate, and the number of steps will be evaluated and their relationship with sleep quality will be determined. Sleep quality will be assessed by the Pittsburgh Sleep Quality Index, sleep duration, heart rate, and step count will be assessed by the Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA), and quality of life will be assessed by the Nottingham Health Profile. The results will be analyzed using the SPSS version 22.0 computer package program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
111 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Relationship Between Sleep Quality, Sleep Duration, Heart Rate, and Step Number in Young Adults
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Healthy young adults group

Face-to-face assessment study

Other: Evaluation of sleep quality, sleep duration, heart rate and step count
Evaluation of sleep quality with the Pittsburgh Sleep Quality Index Evaluation of sleep duration, heart rate, and step count with the Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA) Evaluation of quality of life with the Nottingham Health Profile

Outcome Measures

Primary Outcome Measures

  1. Sleep quality [1 day]

    The Pittsburgh Sleep Quality Index (PSQI) will be used to assess sleep quality. PSQI is a scale that provides information on sleep quality and the type and severity of sleep disturbance in the past week. Turkish validity and reliability were established. In the scale consisting of 24 questions in total, 19 questions are answered by the person, while the other 5 questions are filled by the person's bedmate. 7 sub-dimensions (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping pills, daytime dysfunction) are evaluated with 19 questions answered by the individual. Each item in the scale scores between 0 (no distress)-3 (severe distress). The sum of the scores of the seven subdimensions gives the total PSQI score (between 0-21). Those with a total score of 5≥ "good sleep", and those with a score of 5< are considered "poor sleep quality".

  2. Sleep duration [Single assessment for 1 day]

    Sleep time will be evaluated with the Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA). Individuals will wear a Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA) on one wrist. During a day, individuals' sleep duration will be recorded. They will be asked to continue with their normal routines, in abnormal cases the measurement will be repeated. Data will be transferred via Bluetooth to smartphones or tablets accessible via the Fitbit App. Individuals' privacy will be protected by downloading the Fitbit app only to the principal investigator's device and creating separate accounts, one for each Fitbit device, without providing personal information.

  3. Nottingham Health Profile [1 day]

    The Nottingham Health Profile (NHP) will be used to assess quality of life. The NHP is a general quality of life questionnaire that measures the perceived health problems and the extent to which these problems affect normal daily activities. The questionnaire consists of 38 items. Questions are answered as 'yes' or 'no'. The questionnaire assesses six parameters related to health status. These parameters are; pain (8 items), physical activity (8 items), energy (3 items), sleep (5 items), social isolation (5 items), emotional reactions (9 items). Each subparameter is scored between 0-100. 0 indicates best health, 100 indicates worst health. The total NHP score is derived from the sum of the subscores.

  4. Heart rate [1 day]

    Heart rate count will be evaluated with the Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA). Individuals will wear a Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA) on one wrist. During a day, individuals' heart rate will be recorded. They will be asked to continue with their normal routines, in abnormal cases the measurement will be repeated. Data will be transferred via Bluetooth to smartphones or tablets accessible via the Fitbit App. Individuals' privacy will be protected by downloading the Fitbit app only to the principal investigator's device and creating separate accounts, one for each Fitbit device, without providing personal information.

  5. Step count [1 day]

    Step count will be evaluated with the Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA). Individuals will wear a Fitbit® Inspire 2 (Fitbit, Inc., San Francisco, California, USA) on one wrist. During a day, individuals' step count will be recorded. They will be asked to continue with their normal routines, in abnormal cases the measurement will be repeated. Data will be transferred via Bluetooth to smartphones or tablets accessible via the Fitbit App. Individuals' privacy will be protected by downloading the Fitbit app only to the principal investigator's device and creating separate accounts, one for each Fitbit device, without providing personal information.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Between the ages of 18-30,

  • Without any chronic disease,

  • No past or present mental illness,

  • Can speak, read, and write Turkish and

  • Who volunteered to participate in the study

Exclusion Criteria:
  • With any neurological, psychiatric or cognitive impairment,

  • Who cannot speak, read or write Turkish

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tokat Gaziosmanpasa University Tokat Merkez Turkey 60250

Sponsors and Collaborators

  • Tokat Gaziosmanpasa University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Halime Arikan, Assistant Professor, Tokat Gaziosmanpasa University
ClinicalTrials.gov Identifier:
NCT05829525
Other Study ID Numbers:
  • 83116987-614
First Posted:
Apr 25, 2023
Last Update Posted:
Apr 25, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Halime Arikan, Assistant Professor, Tokat Gaziosmanpasa University

Study Results

No Results Posted as of Apr 25, 2023